nodes	percent_of_prediction	percent_of_DWPC	metapath
Bexarotene—CYP2C9—Gefitinib—lung cancer	0.0563	0.135	CbGbCtD
Bexarotene—CYP2C9—Teniposide—lung cancer	0.0546	0.131	CbGbCtD
Bexarotene—CYP3A4—Topotecan—lung cancer	0.0358	0.0856	CbGbCtD
Bexarotene—CYP3A4—Gefitinib—lung cancer	0.0328	0.0783	CbGbCtD
Bexarotene—CYP3A4—Teniposide—lung cancer	0.0318	0.076	CbGbCtD
Bexarotene—CYP2C9—Paclitaxel—lung cancer	0.0305	0.0729	CbGbCtD
Bexarotene—CYP3A4—Vinorelbine—lung cancer	0.0252	0.0603	CbGbCtD
Bexarotene—CYP2C9—Cisplatin—lung cancer	0.0245	0.0586	CbGbCtD
Bexarotene—CYP3A4—Crizotinib—lung cancer	0.0201	0.048	CbGbCtD
Bexarotene—CYP3A4—Erlotinib—lung cancer	0.0194	0.0463	CbGbCtD
Bexarotene—CYP3A4—Paclitaxel—lung cancer	0.0177	0.0424	CbGbCtD
Bexarotene—CYP3A4—Irinotecan—lung cancer	0.0175	0.0418	CbGbCtD
Bexarotene—CYP3A4—Vinblastine—lung cancer	0.0156	0.0372	CbGbCtD
Bexarotene—CYP3A4—Etoposide—lung cancer	0.014	0.0335	CbGbCtD
Bexarotene—CYP3A4—Docetaxel—lung cancer	0.0128	0.0307	CbGbCtD
Bexarotene—Tamibarotene—RARB—lung cancer	0.0125	1	CrCbGaD
Bexarotene—CYP3A4—Doxorubicin—lung cancer	0.00955	0.0228	CbGbCtD
Bexarotene—Nausea—Vinorelbine—lung cancer	0.000105	0.000278	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Etoposide—lung cancer	0.000105	0.000278	CcSEcCtD
Bexarotene—Dyspepsia—Paclitaxel—lung cancer	0.000105	0.000278	CcSEcCtD
Bexarotene—Body temperature increased—Cisplatin—lung cancer	0.000105	0.000277	CcSEcCtD
Bexarotene—Asthenia—Irinotecan—lung cancer	0.000105	0.000277	CcSEcCtD
Bexarotene—Fatigue—Etoposide—lung cancer	0.000105	0.000277	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000105	0.000277	CcSEcCtD
Bexarotene—Pain—Etoposide—lung cancer	0.000104	0.000275	CcSEcCtD
Bexarotene—Constipation—Etoposide—lung cancer	0.000104	0.000275	CcSEcCtD
Bexarotene—Dysuria—Doxorubicin—lung cancer	0.000104	0.000274	CcSEcCtD
Bexarotene—Neutropenia—Doxorubicin—lung cancer	0.000104	0.000274	CcSEcCtD
Bexarotene—Decreased appetite—Paclitaxel—lung cancer	0.000104	0.000274	CcSEcCtD
Bexarotene—Dry mouth—Docetaxel—lung cancer	0.000103	0.000273	CcSEcCtD
Bexarotene—Haemoglobin—Methotrexate—lung cancer	0.000103	0.000272	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000103	0.000272	CcSEcCtD
Bexarotene—Fatigue—Paclitaxel—lung cancer	0.000103	0.000272	CcSEcCtD
Bexarotene—Haemorrhage—Methotrexate—lung cancer	0.000102	0.000271	CcSEcCtD
Bexarotene—Pollakiuria—Doxorubicin—lung cancer	0.000102	0.000271	CcSEcCtD
Bexarotene—Asthenia—Gemcitabine—lung cancer	0.000102	0.00027	CcSEcCtD
Bexarotene—Pain—Paclitaxel—lung cancer	0.000102	0.00027	CcSEcCtD
Bexarotene—Constipation—Paclitaxel—lung cancer	0.000102	0.00027	CcSEcCtD
Bexarotene—Confusional state—Docetaxel—lung cancer	0.000102	0.000269	CcSEcCtD
Bexarotene—Pharyngitis—Methotrexate—lung cancer	0.000102	0.000269	CcSEcCtD
Bexarotene—Urinary tract disorder—Methotrexate—lung cancer	0.000101	0.000268	CcSEcCtD
Bexarotene—Photosensitivity reaction—Doxorubicin—lung cancer	0.000101	0.000268	CcSEcCtD
Bexarotene—Oedema—Docetaxel—lung cancer	0.000101	0.000267	CcSEcCtD
Bexarotene—Weight increased—Doxorubicin—lung cancer	0.000101	0.000267	CcSEcCtD
Bexarotene—Pruritus—Gemcitabine—lung cancer	0.000101	0.000266	CcSEcCtD
Bexarotene—Urethral disorder—Methotrexate—lung cancer	0.0001	0.000266	CcSEcCtD
Bexarotene—Infection—Docetaxel—lung cancer	0.0001	0.000265	CcSEcCtD
Bexarotene—Weight decreased—Doxorubicin—lung cancer	0.0001	0.000265	CcSEcCtD
Bexarotene—Feeling abnormal—Etoposide—lung cancer	0.0001	0.000265	CcSEcCtD
Bexarotene—Hyperglycaemia—Doxorubicin—lung cancer	0.0001	0.000265	CcSEcCtD
Bexarotene—Diarrhoea—Irinotecan—lung cancer	0.0001	0.000264	CcSEcCtD
Bexarotene—Pneumonia—Doxorubicin—lung cancer	9.94e-05	0.000263	CcSEcCtD
Bexarotene—Gastrointestinal pain—Etoposide—lung cancer	9.94e-05	0.000263	CcSEcCtD
Bexarotene—Shock—Docetaxel—lung cancer	9.94e-05	0.000263	CcSEcCtD
Bexarotene—Nervous system disorder—Docetaxel—lung cancer	9.91e-05	0.000262	CcSEcCtD
Bexarotene—Thrombocytopenia—Docetaxel—lung cancer	9.89e-05	0.000262	CcSEcCtD
Bexarotene—Tachycardia—Docetaxel—lung cancer	9.86e-05	0.000261	CcSEcCtD
Bexarotene—Feeling abnormal—Paclitaxel—lung cancer	9.82e-05	0.00026	CcSEcCtD
Bexarotene—Skin disorder—Docetaxel—lung cancer	9.81e-05	0.00026	CcSEcCtD
Bexarotene—Hypersensitivity—Cisplatin—lung cancer	9.77e-05	0.000259	CcSEcCtD
Bexarotene—Gastrointestinal pain—Paclitaxel—lung cancer	9.74e-05	0.000258	CcSEcCtD
Bexarotene—Diarrhoea—Gemcitabine—lung cancer	9.74e-05	0.000258	CcSEcCtD
Bexarotene—Neuropathy peripheral—Doxorubicin—lung cancer	9.69e-05	0.000256	CcSEcCtD
Bexarotene—Dizziness—Irinotecan—lung cancer	9.66e-05	0.000256	CcSEcCtD
Bexarotene—Stomatitis—Doxorubicin—lung cancer	9.63e-05	0.000255	CcSEcCtD
Bexarotene—Jaundice—Doxorubicin—lung cancer	9.63e-05	0.000255	CcSEcCtD
Bexarotene—Anorexia—Docetaxel—lung cancer	9.63e-05	0.000255	CcSEcCtD
Bexarotene—Abdominal pain—Etoposide—lung cancer	9.61e-05	0.000254	CcSEcCtD
Bexarotene—Body temperature increased—Etoposide—lung cancer	9.61e-05	0.000254	CcSEcCtD
Bexarotene—Urinary tract infection—Doxorubicin—lung cancer	9.61e-05	0.000254	CcSEcCtD
Bexarotene—Conjunctivitis—Doxorubicin—lung cancer	9.61e-05	0.000254	CcSEcCtD
Bexarotene—Eye disorder—Methotrexate—lung cancer	9.58e-05	0.000253	CcSEcCtD
Bexarotene—Tinnitus—Methotrexate—lung cancer	9.55e-05	0.000253	CcSEcCtD
Bexarotene—Asthenia—Cisplatin—lung cancer	9.52e-05	0.000252	CcSEcCtD
Bexarotene—Cardiac disorder—Methotrexate—lung cancer	9.51e-05	0.000252	CcSEcCtD
Bexarotene—Sweating—Doxorubicin—lung cancer	9.48e-05	0.000251	CcSEcCtD
Bexarotene—Haematuria—Doxorubicin—lung cancer	9.42e-05	0.000249	CcSEcCtD
Bexarotene—Abdominal pain—Paclitaxel—lung cancer	9.42e-05	0.000249	CcSEcCtD
Bexarotene—Body temperature increased—Paclitaxel—lung cancer	9.42e-05	0.000249	CcSEcCtD
Bexarotene—Epistaxis—Doxorubicin—lung cancer	9.32e-05	0.000247	CcSEcCtD
Bexarotene—Angiopathy—Methotrexate—lung cancer	9.3e-05	0.000246	CcSEcCtD
Bexarotene—Vomiting—Irinotecan—lung cancer	9.29e-05	0.000246	CcSEcCtD
Bexarotene—Sinusitis—Doxorubicin—lung cancer	9.27e-05	0.000245	CcSEcCtD
Bexarotene—Rash—Irinotecan—lung cancer	9.21e-05	0.000244	CcSEcCtD
Bexarotene—Dermatitis—Irinotecan—lung cancer	9.2e-05	0.000244	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Docetaxel—lung cancer	9.2e-05	0.000243	CcSEcCtD
Bexarotene—Chills—Methotrexate—lung cancer	9.19e-05	0.000243	CcSEcCtD
Bexarotene—Headache—Irinotecan—lung cancer	9.15e-05	0.000242	CcSEcCtD
Bexarotene—Insomnia—Docetaxel—lung cancer	9.14e-05	0.000242	CcSEcCtD
Bexarotene—Diarrhoea—Cisplatin—lung cancer	9.08e-05	0.00024	CcSEcCtD
Bexarotene—Paraesthesia—Docetaxel—lung cancer	9.07e-05	0.00024	CcSEcCtD
Bexarotene—Alopecia—Methotrexate—lung cancer	9.06e-05	0.00024	CcSEcCtD
Bexarotene—Vomiting—Gemcitabine—lung cancer	9.05e-05	0.000239	CcSEcCtD
Bexarotene—Dyspnoea—Docetaxel—lung cancer	9.01e-05	0.000238	CcSEcCtD
Bexarotene—Somnolence—Docetaxel—lung cancer	8.98e-05	0.000238	CcSEcCtD
Bexarotene—Rash—Gemcitabine—lung cancer	8.97e-05	0.000237	CcSEcCtD
Bexarotene—Dermatitis—Gemcitabine—lung cancer	8.97e-05	0.000237	CcSEcCtD
Bexarotene—Hypersensitivity—Etoposide—lung cancer	8.95e-05	0.000237	CcSEcCtD
Bexarotene—Malnutrition—Methotrexate—lung cancer	8.92e-05	0.000236	CcSEcCtD
Bexarotene—Erythema—Methotrexate—lung cancer	8.92e-05	0.000236	CcSEcCtD
Bexarotene—Haemoglobin—Doxorubicin—lung cancer	8.92e-05	0.000236	CcSEcCtD
Bexarotene—Headache—Gemcitabine—lung cancer	8.92e-05	0.000236	CcSEcCtD
Bexarotene—Rhinitis—Doxorubicin—lung cancer	8.9e-05	0.000235	CcSEcCtD
Bexarotene—Dyspepsia—Docetaxel—lung cancer	8.89e-05	0.000235	CcSEcCtD
Bexarotene—Haemorrhage—Doxorubicin—lung cancer	8.87e-05	0.000235	CcSEcCtD
Bexarotene—Hypoaesthesia—Doxorubicin—lung cancer	8.83e-05	0.000234	CcSEcCtD
Bexarotene—Pharyngitis—Doxorubicin—lung cancer	8.81e-05	0.000233	CcSEcCtD
Bexarotene—Decreased appetite—Docetaxel—lung cancer	8.78e-05	0.000232	CcSEcCtD
Bexarotene—Hypersensitivity—Paclitaxel—lung cancer	8.78e-05	0.000232	CcSEcCtD
Bexarotene—Urinary tract disorder—Doxorubicin—lung cancer	8.76e-05	0.000232	CcSEcCtD
Bexarotene—Oedema peripheral—Doxorubicin—lung cancer	8.74e-05	0.000231	CcSEcCtD
Bexarotene—Dysgeusia—Methotrexate—lung cancer	8.74e-05	0.000231	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Docetaxel—lung cancer	8.72e-05	0.000231	CcSEcCtD
Bexarotene—Asthenia—Etoposide—lung cancer	8.72e-05	0.000231	CcSEcCtD
Bexarotene—Connective tissue disorder—Doxorubicin—lung cancer	8.72e-05	0.000231	CcSEcCtD
Bexarotene—Fatigue—Docetaxel—lung cancer	8.71e-05	0.00023	CcSEcCtD
Bexarotene—Urethral disorder—Doxorubicin—lung cancer	8.7e-05	0.00023	CcSEcCtD
Bexarotene—Nausea—Irinotecan—lung cancer	8.68e-05	0.00023	CcSEcCtD
Bexarotene—Pain—Docetaxel—lung cancer	8.64e-05	0.000229	CcSEcCtD
Bexarotene—Constipation—Docetaxel—lung cancer	8.64e-05	0.000229	CcSEcCtD
Bexarotene—Back pain—Methotrexate—lung cancer	8.63e-05	0.000228	CcSEcCtD
Bexarotene—Pruritus—Etoposide—lung cancer	8.6e-05	0.000227	CcSEcCtD
Bexarotene—Asthenia—Paclitaxel—lung cancer	8.55e-05	0.000226	CcSEcCtD
Bexarotene—Nausea—Gemcitabine—lung cancer	8.45e-05	0.000224	CcSEcCtD
Bexarotene—Vomiting—Cisplatin—lung cancer	8.44e-05	0.000223	CcSEcCtD
Bexarotene—Pruritus—Paclitaxel—lung cancer	8.43e-05	0.000223	CcSEcCtD
Bexarotene—Rash—Cisplatin—lung cancer	8.37e-05	0.000221	CcSEcCtD
Bexarotene—Dermatitis—Cisplatin—lung cancer	8.36e-05	0.000221	CcSEcCtD
Bexarotene—Feeling abnormal—Docetaxel—lung cancer	8.32e-05	0.00022	CcSEcCtD
Bexarotene—Diarrhoea—Etoposide—lung cancer	8.32e-05	0.00022	CcSEcCtD
Bexarotene—Eye disorder—Doxorubicin—lung cancer	8.29e-05	0.000219	CcSEcCtD
Bexarotene—Ill-defined disorder—Methotrexate—lung cancer	8.28e-05	0.000219	CcSEcCtD
Bexarotene—Tinnitus—Doxorubicin—lung cancer	8.27e-05	0.000219	CcSEcCtD
Bexarotene—Gastrointestinal pain—Docetaxel—lung cancer	8.26e-05	0.000219	CcSEcCtD
Bexarotene—Anaemia—Methotrexate—lung cancer	8.24e-05	0.000218	CcSEcCtD
Bexarotene—Cardiac disorder—Doxorubicin—lung cancer	8.23e-05	0.000218	CcSEcCtD
Bexarotene—Diarrhoea—Paclitaxel—lung cancer	8.15e-05	0.000216	CcSEcCtD
Bexarotene—Angiopathy—Doxorubicin—lung cancer	8.05e-05	0.000213	CcSEcCtD
Bexarotene—Malaise—Methotrexate—lung cancer	8.04e-05	0.000213	CcSEcCtD
Bexarotene—Dizziness—Etoposide—lung cancer	8.04e-05	0.000213	CcSEcCtD
Bexarotene—Vertigo—Methotrexate—lung cancer	8.01e-05	0.000212	CcSEcCtD
Bexarotene—Abdominal pain—Docetaxel—lung cancer	7.98e-05	0.000211	CcSEcCtD
Bexarotene—Body temperature increased—Docetaxel—lung cancer	7.98e-05	0.000211	CcSEcCtD
Bexarotene—Leukopenia—Methotrexate—lung cancer	7.98e-05	0.000211	CcSEcCtD
Bexarotene—Chills—Doxorubicin—lung cancer	7.96e-05	0.000211	CcSEcCtD
Bexarotene—Arrhythmia—Doxorubicin—lung cancer	7.93e-05	0.00021	CcSEcCtD
Bexarotene—Dizziness—Paclitaxel—lung cancer	7.88e-05	0.000208	CcSEcCtD
Bexarotene—Nausea—Cisplatin—lung cancer	7.88e-05	0.000208	CcSEcCtD
Bexarotene—Alopecia—Doxorubicin—lung cancer	7.84e-05	0.000207	CcSEcCtD
Bexarotene—Cough—Methotrexate—lung cancer	7.78e-05	0.000206	CcSEcCtD
Bexarotene—Vomiting—Etoposide—lung cancer	7.73e-05	0.000204	CcSEcCtD
Bexarotene—Erythema—Doxorubicin—lung cancer	7.72e-05	0.000204	CcSEcCtD
Bexarotene—Malnutrition—Doxorubicin—lung cancer	7.72e-05	0.000204	CcSEcCtD
Bexarotene—Rash—Etoposide—lung cancer	7.66e-05	0.000203	CcSEcCtD
Bexarotene—Dermatitis—Etoposide—lung cancer	7.66e-05	0.000203	CcSEcCtD
Bexarotene—Headache—Etoposide—lung cancer	7.61e-05	0.000201	CcSEcCtD
Bexarotene—Flatulence—Doxorubicin—lung cancer	7.61e-05	0.000201	CcSEcCtD
Bexarotene—Arthralgia—Methotrexate—lung cancer	7.59e-05	0.000201	CcSEcCtD
Bexarotene—Chest pain—Methotrexate—lung cancer	7.59e-05	0.000201	CcSEcCtD
Bexarotene—Myalgia—Methotrexate—lung cancer	7.59e-05	0.000201	CcSEcCtD
Bexarotene—Tension—Doxorubicin—lung cancer	7.58e-05	0.000201	CcSEcCtD
Bexarotene—Vomiting—Paclitaxel—lung cancer	7.58e-05	0.0002	CcSEcCtD
Bexarotene—Dysgeusia—Doxorubicin—lung cancer	7.56e-05	0.0002	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	7.54e-05	0.0002	CcSEcCtD
Bexarotene—Rash—Paclitaxel—lung cancer	7.51e-05	0.000199	CcSEcCtD
Bexarotene—Dermatitis—Paclitaxel—lung cancer	7.51e-05	0.000199	CcSEcCtD
Bexarotene—Discomfort—Methotrexate—lung cancer	7.5e-05	0.000199	CcSEcCtD
Bexarotene—Nervousness—Doxorubicin—lung cancer	7.5e-05	0.000198	CcSEcCtD
Bexarotene—Back pain—Doxorubicin—lung cancer	7.47e-05	0.000198	CcSEcCtD
Bexarotene—Headache—Paclitaxel—lung cancer	7.47e-05	0.000198	CcSEcCtD
Bexarotene—Hypersensitivity—Docetaxel—lung cancer	7.44e-05	0.000197	CcSEcCtD
Bexarotene—Muscle spasms—Doxorubicin—lung cancer	7.43e-05	0.000196	CcSEcCtD
Bexarotene—Confusional state—Methotrexate—lung cancer	7.34e-05	0.000194	CcSEcCtD
Bexarotene—Asthenia—Docetaxel—lung cancer	7.25e-05	0.000192	CcSEcCtD
Bexarotene—Infection—Methotrexate—lung cancer	7.23e-05	0.000191	CcSEcCtD
Bexarotene—Nausea—Etoposide—lung cancer	7.22e-05	0.000191	CcSEcCtD
Bexarotene—Ill-defined disorder—Doxorubicin—lung cancer	7.17e-05	0.00019	CcSEcCtD
Bexarotene—Pruritus—Docetaxel—lung cancer	7.15e-05	0.000189	CcSEcCtD
Bexarotene—Nervous system disorder—Methotrexate—lung cancer	7.14e-05	0.000189	CcSEcCtD
Bexarotene—Anaemia—Doxorubicin—lung cancer	7.14e-05	0.000189	CcSEcCtD
Bexarotene—Thrombocytopenia—Methotrexate—lung cancer	7.13e-05	0.000189	CcSEcCtD
Bexarotene—Agitation—Doxorubicin—lung cancer	7.1e-05	0.000188	CcSEcCtD
Bexarotene—Nausea—Paclitaxel—lung cancer	7.08e-05	0.000187	CcSEcCtD
Bexarotene—Skin disorder—Methotrexate—lung cancer	7.07e-05	0.000187	CcSEcCtD
Bexarotene—Hyperhidrosis—Methotrexate—lung cancer	7.04e-05	0.000186	CcSEcCtD
Bexarotene—Malaise—Doxorubicin—lung cancer	6.97e-05	0.000184	CcSEcCtD
Bexarotene—Vertigo—Doxorubicin—lung cancer	6.94e-05	0.000184	CcSEcCtD
Bexarotene—Anorexia—Methotrexate—lung cancer	6.94e-05	0.000184	CcSEcCtD
Bexarotene—Syncope—Doxorubicin—lung cancer	6.93e-05	0.000183	CcSEcCtD
Bexarotene—Leukopenia—Doxorubicin—lung cancer	6.91e-05	0.000183	CcSEcCtD
Bexarotene—Diarrhoea—Docetaxel—lung cancer	6.91e-05	0.000183	CcSEcCtD
Bexarotene—Palpitations—Doxorubicin—lung cancer	6.83e-05	0.000181	CcSEcCtD
Bexarotene—Loss of consciousness—Doxorubicin—lung cancer	6.79e-05	0.00018	CcSEcCtD
Bexarotene—Cough—Doxorubicin—lung cancer	6.74e-05	0.000178	CcSEcCtD
Bexarotene—Dizziness—Docetaxel—lung cancer	6.68e-05	0.000177	CcSEcCtD
Bexarotene—Hypertension—Doxorubicin—lung cancer	6.67e-05	0.000176	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Methotrexate—lung cancer	6.63e-05	0.000175	CcSEcCtD
Bexarotene—Insomnia—Methotrexate—lung cancer	6.58e-05	0.000174	CcSEcCtD
Bexarotene—Arthralgia—Doxorubicin—lung cancer	6.58e-05	0.000174	CcSEcCtD
Bexarotene—Chest pain—Doxorubicin—lung cancer	6.58e-05	0.000174	CcSEcCtD
Bexarotene—Myalgia—Doxorubicin—lung cancer	6.58e-05	0.000174	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	6.57e-05	0.000343	CbGpPWpGaD
Bexarotene—Anxiety—Doxorubicin—lung cancer	6.55e-05	0.000173	CcSEcCtD
Bexarotene—Paraesthesia—Methotrexate—lung cancer	6.54e-05	0.000173	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	6.53e-05	0.000173	CcSEcCtD
Bexarotene—RXRA—Adipogenesis—IL6—lung cancer	6.53e-05	0.000341	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—B4GALT5—lung cancer	6.51e-05	0.00034	CbGpPWpGaD
Bexarotene—Discomfort—Doxorubicin—lung cancer	6.5e-05	0.000172	CcSEcCtD
Bexarotene—CYP3A4—Biological oxidations—GCLC—lung cancer	6.49e-05	0.000339	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—CYP2A6—lung cancer	6.49e-05	0.000339	CbGpPWpGaD
Bexarotene—Dyspnoea—Methotrexate—lung cancer	6.49e-05	0.000172	CcSEcCtD
Bexarotene—RXRG—Generic Transcription Pathway—MYC—lung cancer	6.47e-05	0.000338	CbGpPWpGaD
Bexarotene—Somnolence—Methotrexate—lung cancer	6.47e-05	0.000171	CcSEcCtD
Bexarotene—Dry mouth—Doxorubicin—lung cancer	6.43e-05	0.00017	CcSEcCtD
Bexarotene—Vomiting—Docetaxel—lung cancer	6.42e-05	0.00017	CcSEcCtD
Bexarotene—Dyspepsia—Methotrexate—lung cancer	6.41e-05	0.00017	CcSEcCtD
Bexarotene—RXRA—Transmembrane transport of small molecules—ABCB1—lung cancer	6.39e-05	0.000334	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	6.39e-05	0.000334	CbGpPWpGaD
Bexarotene—Rash—Docetaxel—lung cancer	6.37e-05	0.000168	CcSEcCtD
Bexarotene—Dermatitis—Docetaxel—lung cancer	6.36e-05	0.000168	CcSEcCtD
Bexarotene—Confusional state—Doxorubicin—lung cancer	6.36e-05	0.000168	CcSEcCtD
Bexarotene—CYP2C9—Biological oxidations—GSTM1—lung cancer	6.35e-05	0.000332	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GSTA4—lung cancer	6.33e-05	0.000331	CbGpPWpGaD
Bexarotene—Decreased appetite—Methotrexate—lung cancer	6.33e-05	0.000167	CcSEcCtD
Bexarotene—Headache—Docetaxel—lung cancer	6.33e-05	0.000167	CcSEcCtD
Bexarotene—Oedema—Doxorubicin—lung cancer	6.3e-05	0.000167	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Methotrexate—lung cancer	6.29e-05	0.000166	CcSEcCtD
Bexarotene—Fatigue—Methotrexate—lung cancer	6.28e-05	0.000166	CcSEcCtD
Bexarotene—Infection—Doxorubicin—lung cancer	6.26e-05	0.000166	CcSEcCtD
Bexarotene—CYP2C9—Metapathway biotransformation—GSTM1—lung cancer	6.26e-05	0.000327	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—FGFR1—lung cancer	6.25e-05	0.000327	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	6.25e-05	0.000326	CbGpPWpGaD
Bexarotene—Pain—Methotrexate—lung cancer	6.23e-05	0.000165	CcSEcCtD
Bexarotene—Shock—Doxorubicin—lung cancer	6.2e-05	0.000164	CcSEcCtD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	6.19e-05	0.000323	CbGpPWpGaD
Bexarotene—Nervous system disorder—Doxorubicin—lung cancer	6.18e-05	0.000164	CcSEcCtD
Bexarotene—Thrombocytopenia—Doxorubicin—lung cancer	6.17e-05	0.000163	CcSEcCtD
Bexarotene—RXRA—Metabolism—GSTA2—lung cancer	6.17e-05	0.000322	CbGpPWpGaD
Bexarotene—Tachycardia—Doxorubicin—lung cancer	6.15e-05	0.000163	CcSEcCtD
Bexarotene—Skin disorder—Doxorubicin—lung cancer	6.12e-05	0.000162	CcSEcCtD
Bexarotene—Hyperhidrosis—Doxorubicin—lung cancer	6.09e-05	0.000161	CcSEcCtD
Bexarotene—RXRB—Generic Transcription Pathway—MYC—lung cancer	6.09e-05	0.000318	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—CYP1A1—lung cancer	6.02e-05	0.000314	CbGpPWpGaD
Bexarotene—Anorexia—Doxorubicin—lung cancer	6.01e-05	0.000159	CcSEcCtD
Bexarotene—Nausea—Docetaxel—lung cancer	6e-05	0.000159	CcSEcCtD
Bexarotene—Feeling abnormal—Methotrexate—lung cancer	6e-05	0.000159	CcSEcCtD
Bexarotene—Gastrointestinal pain—Methotrexate—lung cancer	5.95e-05	0.000157	CcSEcCtD
Bexarotene—RXRA—Metabolism—GSTA1—lung cancer	5.95e-05	0.000311	CbGpPWpGaD
Bexarotene—CYP2C9—Metapathway biotransformation—CYP1A1—lung cancer	5.93e-05	0.00031	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	5.9e-05	0.000308	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—KDR—lung cancer	5.89e-05	0.000308	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ABCC3—lung cancer	5.89e-05	0.000308	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—HSPB1—lung cancer	5.8e-05	0.000303	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MET—lung cancer	5.76e-05	0.000301	CbGpPWpGaD
Bexarotene—Body temperature increased—Methotrexate—lung cancer	5.76e-05	0.000152	CcSEcCtD
Bexarotene—Abdominal pain—Methotrexate—lung cancer	5.76e-05	0.000152	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Doxorubicin—lung cancer	5.74e-05	0.000152	CcSEcCtD
Bexarotene—Insomnia—Doxorubicin—lung cancer	5.7e-05	0.000151	CcSEcCtD
Bexarotene—RXRA—Metabolism—AKR1C1—lung cancer	5.7e-05	0.000298	CbGpPWpGaD
Bexarotene—Paraesthesia—Doxorubicin—lung cancer	5.66e-05	0.00015	CcSEcCtD
Bexarotene—Dyspnoea—Doxorubicin—lung cancer	5.62e-05	0.000149	CcSEcCtD
Bexarotene—Somnolence—Doxorubicin—lung cancer	5.6e-05	0.000148	CcSEcCtD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	5.57e-05	0.000291	CbGpPWpGaD
Bexarotene—Dyspepsia—Doxorubicin—lung cancer	5.55e-05	0.000147	CcSEcCtD
Bexarotene—RXRA—Metabolism—UGT1A1—lung cancer	5.53e-05	0.000289	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—CYP2E1—lung cancer	5.52e-05	0.000289	CbGpPWpGaD
Bexarotene—Decreased appetite—Doxorubicin—lung cancer	5.48e-05	0.000145	CcSEcCtD
Bexarotene—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	5.45e-05	0.000285	CbGpPWpGaD
Bexarotene—Gastrointestinal disorder—Doxorubicin—lung cancer	5.44e-05	0.000144	CcSEcCtD
Bexarotene—Fatigue—Doxorubicin—lung cancer	5.43e-05	0.000144	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	5.42e-05	0.000283	CbGpPWpGaD
Bexarotene—Pain—Doxorubicin—lung cancer	5.39e-05	0.000143	CcSEcCtD
Bexarotene—Constipation—Doxorubicin—lung cancer	5.39e-05	0.000143	CcSEcCtD
Bexarotene—Hypersensitivity—Methotrexate—lung cancer	5.36e-05	0.000142	CcSEcCtD
Bexarotene—RXRA—Generic Transcription Pathway—CREBBP—lung cancer	5.35e-05	0.000279	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GNG11—lung cancer	5.34e-05	0.000279	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—APOA1—lung cancer	5.31e-05	0.000277	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—AZIN2—lung cancer	5.29e-05	0.000276	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—COL4A3BP—lung cancer	5.29e-05	0.000276	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—CREBBP—lung cancer	5.25e-05	0.000274	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	5.24e-05	0.000274	CbGpPWpGaD
Bexarotene—Asthenia—Methotrexate—lung cancer	5.22e-05	0.000138	CcSEcCtD
Bexarotene—Feeling abnormal—Doxorubicin—lung cancer	5.19e-05	0.000137	CcSEcCtD
Bexarotene—Gastrointestinal pain—Doxorubicin—lung cancer	5.15e-05	0.000136	CcSEcCtD
Bexarotene—Pruritus—Methotrexate—lung cancer	5.15e-05	0.000136	CcSEcCtD
Bexarotene—RXRA—Gene Expression—NOTCH3—lung cancer	5.11e-05	0.000267	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ALDOA—lung cancer	5.08e-05	0.000265	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—APOA1—lung cancer	5.05e-05	0.000264	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—IL6R—lung cancer	5.04e-05	0.000263	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—CREBBP—lung cancer	5.03e-05	0.000263	CbGpPWpGaD
Bexarotene—Body temperature increased—Doxorubicin—lung cancer	4.98e-05	0.000132	CcSEcCtD
Bexarotene—Abdominal pain—Doxorubicin—lung cancer	4.98e-05	0.000132	CcSEcCtD
Bexarotene—Diarrhoea—Methotrexate—lung cancer	4.98e-05	0.000132	CcSEcCtD
Bexarotene—RXRB—Gene Expression—CREBBP—lung cancer	4.94e-05	0.000258	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	4.93e-05	0.000258	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—NCOA3—lung cancer	4.93e-05	0.000258	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	4.85e-05	0.000253	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—JUNB—lung cancer	4.84e-05	0.000253	CbGpPWpGaD
Bexarotene—Dizziness—Methotrexate—lung cancer	4.81e-05	0.000127	CcSEcCtD
Bexarotene—RXRA—Developmental Biology—MMP2—lung cancer	4.81e-05	0.000251	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MAP2K1—lung cancer	4.8e-05	0.000251	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ABCG2—lung cancer	4.8e-05	0.000251	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ADCY1—lung cancer	4.8e-05	0.000251	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	4.78e-05	0.00025	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—HPGDS—lung cancer	4.7e-05	0.000246	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ENO2—lung cancer	4.7e-05	0.000246	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PPP2R1B—lung cancer	4.68e-05	0.000244	CbGpPWpGaD
Bexarotene—Hypersensitivity—Doxorubicin—lung cancer	4.64e-05	0.000123	CcSEcCtD
Bexarotene—Vomiting—Methotrexate—lung cancer	4.63e-05	0.000122	CcSEcCtD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—POMC—lung cancer	4.61e-05	0.000241	CbGpPWpGaD
Bexarotene—Rash—Methotrexate—lung cancer	4.59e-05	0.000121	CcSEcCtD
Bexarotene—Dermatitis—Methotrexate—lung cancer	4.59e-05	0.000121	CcSEcCtD
Bexarotene—RXRA—Metabolism—GSTT1—lung cancer	4.56e-05	0.000238	CbGpPWpGaD
Bexarotene—Headache—Methotrexate—lung cancer	4.56e-05	0.000121	CcSEcCtD
Bexarotene—CYP3A4—Biological oxidations—GSTP1—lung cancer	4.55e-05	0.000238	CbGpPWpGaD
Bexarotene—Asthenia—Doxorubicin—lung cancer	4.52e-05	0.00012	CcSEcCtD
Bexarotene—RXRA—Metabolism—GCLC—lung cancer	4.51e-05	0.000236	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CYP2A6—lung cancer	4.51e-05	0.000236	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ATP5H—lung cancer	4.5e-05	0.000235	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	4.49e-05	0.000235	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	4.49e-05	0.000235	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—POMC—lung cancer	4.48e-05	0.000234	CbGpPWpGaD
Bexarotene—Pruritus—Doxorubicin—lung cancer	4.46e-05	0.000118	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	4.43e-05	0.000231	CbGpPWpGaD
Bexarotene—Nausea—Methotrexate—lung cancer	4.32e-05	0.000114	CcSEcCtD
Bexarotene—Diarrhoea—Doxorubicin—lung cancer	4.31e-05	0.000114	CcSEcCtD
Bexarotene—RXRA—Metabolism—ENO1—lung cancer	4.28e-05	0.000223	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—CREBBP—lung cancer	4.27e-05	0.000223	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	4.26e-05	0.000223	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—RAF1—lung cancer	4.26e-05	0.000223	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—ERBB2—lung cancer	4.21e-05	0.00022	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—ALB—lung cancer	4.21e-05	0.00022	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—GSTM1—lung cancer	4.18e-05	0.000219	CbGpPWpGaD
Bexarotene—Dizziness—Doxorubicin—lung cancer	4.17e-05	0.00011	CcSEcCtD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	4.13e-05	0.000216	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	4.13e-05	0.000216	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PLBD1—lung cancer	4.01e-05	0.00021	CbGpPWpGaD
Bexarotene—Vomiting—Doxorubicin—lung cancer	4.01e-05	0.000106	CcSEcCtD
Bexarotene—RXRA—Transmembrane transport of small molecules—ALB—lung cancer	4e-05	0.000209	CbGpPWpGaD
Bexarotene—Rash—Doxorubicin—lung cancer	3.97e-05	0.000105	CcSEcCtD
Bexarotene—Dermatitis—Doxorubicin—lung cancer	3.97e-05	0.000105	CcSEcCtD
Bexarotene—CYP3A4—Biological oxidations—CYP1A1—lung cancer	3.97e-05	0.000207	CbGpPWpGaD
Bexarotene—Headache—Doxorubicin—lung cancer	3.95e-05	0.000104	CcSEcCtD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	3.94e-05	0.000206	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	3.91e-05	0.000204	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CYP2E1—lung cancer	3.84e-05	0.0002	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—NQO1—lung cancer	3.79e-05	0.000198	CbGpPWpGaD
Bexarotene—Nausea—Doxorubicin—lung cancer	3.74e-05	9.91e-05	CcSEcCtD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.71e-05	0.000194	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.68e-05	0.000192	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HSD17B10—lung cancer	3.67e-05	0.000192	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—RAF1—lung cancer	3.62e-05	0.000189	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MMP9—lung cancer	3.61e-05	0.000189	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—ERCC2—lung cancer	3.51e-05	0.000184	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—COL4A3BP—lung cancer	3.49e-05	0.000182	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—AZIN2—lung cancer	3.49e-05	0.000182	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—EP300—lung cancer	3.43e-05	0.000179	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—STK11—lung cancer	3.42e-05	0.000179	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CKB—lung cancer	3.41e-05	0.000178	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—SRC—lung cancer	3.33e-05	0.000174	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—VEGFA—lung cancer	3.25e-05	0.00017	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—STAT3—lung cancer	3.21e-05	0.000168	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.21e-05	0.000168	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CNDP2—lung cancer	3.21e-05	0.000168	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTM2—lung cancer	3.21e-05	0.000168	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—NRAS—lung cancer	3.21e-05	0.000168	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—MAPK3—lung cancer	3.2e-05	0.000167	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—MYC—lung cancer	3.17e-05	0.000166	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GSTP1—lung cancer	3.16e-05	0.000165	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—MTMR3—lung cancer	3.12e-05	0.000163	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—MYC—lung cancer	3.12e-05	0.000163	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CAT—lung cancer	3.08e-05	0.000161	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MAPK3—lung cancer	3.07e-05	0.00016	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.06e-05	0.00016	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PGAM1—lung cancer	3.04e-05	0.000159	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—MAPK3—lung cancer	3.01e-05	0.000157	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ABCB1—lung cancer	2.99e-05	0.000156	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ATP5H—lung cancer	2.97e-05	0.000155	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—POMC—lung cancer	2.96e-05	0.000155	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—TYMS—lung cancer	2.94e-05	0.000154	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—MYC—lung cancer	2.93e-05	0.000153	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—EGFR—lung cancer	2.92e-05	0.000153	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GSTM1—lung cancer	2.91e-05	0.000152	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP2A7—lung cancer	2.9e-05	0.000151	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SDC4—lung cancer	2.84e-05	0.000148	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—KRAS—lung cancer	2.76e-05	0.000144	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CYP1A1—lung cancer	2.76e-05	0.000144	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ERCC2—lung cancer	2.73e-05	0.000143	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PLBD1—lung cancer	2.64e-05	0.000138	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—RRM1—lung cancer	2.58e-05	0.000135	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTA3—lung cancer	2.58e-05	0.000135	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—CREBBP—lung cancer	2.57e-05	0.000134	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—B4GALT5—lung cancer	2.43e-05	0.000127	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HSD17B10—lung cancer	2.42e-05	0.000126	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—APOA1—lung cancer	2.36e-05	0.000124	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTA4—lung cancer	2.36e-05	0.000123	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—HRAS—lung cancer	2.35e-05	0.000123	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	2.31e-05	0.000121	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTA2—lung cancer	2.3e-05	0.00012	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.26e-05	0.000118	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CKB—lung cancer	2.25e-05	0.000118	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—IL6—lung cancer	2.24e-05	0.000117	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTA1—lung cancer	2.22e-05	0.000116	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ABCC3—lung cancer	2.2e-05	0.000115	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—AKT1—lung cancer	2.16e-05	0.000113	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PIK3CG—lung cancer	2.16e-05	0.000113	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—AKR1C1—lung cancer	2.13e-05	0.000111	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CNDP2—lung cancer	2.11e-05	0.00011	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTM2—lung cancer	2.11e-05	0.00011	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—AKT1—lung cancer	2.07e-05	0.000108	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—UGT1A1—lung cancer	2.07e-05	0.000108	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—MTMR3—lung cancer	2.06e-05	0.000107	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—POMC—lung cancer	2.05e-05	0.000107	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—AKT1—lung cancer	2.03e-05	0.000106	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PGAM1—lung cancer	2e-05	0.000105	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CREBBP—lung cancer	2e-05	0.000105	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GNG11—lung cancer	1.99e-05	0.000104	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.98e-05	0.000104	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP2A7—lung cancer	1.91e-05	9.99e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PIK3CD—lung cancer	1.9e-05	9.91e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ALDOA—lung cancer	1.9e-05	9.91e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ALB—lung cancer	1.87e-05	9.79e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SDC4—lung cancer	1.87e-05	9.78e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—NCOA3—lung cancer	1.84e-05	9.62e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.81e-05	9.45e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ADCY1—lung cancer	1.79e-05	9.36e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ABCG2—lung cancer	1.79e-05	9.36e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HPGDS—lung cancer	1.76e-05	9.18e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ENO2—lung cancer	1.76e-05	9.18e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PPP2R1B—lung cancer	1.75e-05	9.12e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.72e-05	9e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—RRM1—lung cancer	1.7e-05	8.91e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTA3—lung cancer	1.7e-05	8.91e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTT1—lung cancer	1.7e-05	8.9e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP2A6—lung cancer	1.68e-05	8.8e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GCLC—lung cancer	1.68e-05	8.8e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.68e-05	8.77e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PIK3CB—lung cancer	1.65e-05	8.64e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PTGS2—lung cancer	1.64e-05	8.56e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—B4GALT5—lung cancer	1.6e-05	8.37e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ENO1—lung cancer	1.6e-05	8.34e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.59e-05	8.31e-05	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—MAPK3—lung cancer	1.57e-05	8.21e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.57e-05	8.2e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTA4—lung cancer	1.56e-05	8.14e-05	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—MYC—lung cancer	1.53e-05	7.98e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTA2—lung cancer	1.52e-05	7.94e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTA1—lung cancer	1.47e-05	7.66e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ABCC3—lung cancer	1.45e-05	7.57e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP2E1—lung cancer	1.43e-05	7.48e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PTEN—lung cancer	1.43e-05	7.47e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—NQO1—lung cancer	1.42e-05	7.4e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—AKR1C1—lung cancer	1.4e-05	7.33e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.39e-05	7.24e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.37e-05	7.18e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—EP300—lung cancer	1.36e-05	7.12e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—UGT1A1—lung cancer	1.36e-05	7.12e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GNG11—lung cancer	1.31e-05	6.86e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—STK11—lung cancer	1.28e-05	6.67e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALDOA—lung cancer	1.25e-05	6.54e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NCOA3—lung cancer	1.21e-05	6.35e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.2e-05	6.26e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ADCY1—lung cancer	1.18e-05	6.17e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ABCG2—lung cancer	1.18e-05	6.17e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTP1—lung cancer	1.18e-05	6.17e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HPGDS—lung cancer	1.16e-05	6.05e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ENO2—lung cancer	1.16e-05	6.05e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.15e-05	6.02e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CAT—lung cancer	1.15e-05	6e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.14e-05	5.97e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTT1—lung cancer	1.12e-05	5.87e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ABCB1—lung cancer	1.12e-05	5.84e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP2A6—lung cancer	1.11e-05	5.8e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GCLC—lung cancer	1.11e-05	5.8e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—TYMS—lung cancer	1.1e-05	5.74e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTM1—lung cancer	1.09e-05	5.67e-05	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—AKT1—lung cancer	1.06e-05	5.53e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ENO1—lung cancer	1.05e-05	5.5e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP1A1—lung cancer	1.03e-05	5.38e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ERCC2—lung cancer	1.02e-05	5.33e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PIK3CA—lung cancer	1.01e-05	5.27e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP2E1—lung cancer	9.44e-06	4.93e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NQO1—lung cancer	9.34e-06	4.88e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—APOA1—lung cancer	8.83e-06	4.61e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	8.45e-06	4.42e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—STK11—lung cancer	8.42e-06	4.4e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—AKT1—lung cancer	8.24e-06	4.3e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PIK3CG—lung cancer	8.06e-06	4.21e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTP1—lung cancer	7.79e-06	4.07e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—POMC—lung cancer	7.67e-06	4.01e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CAT—lung cancer	7.58e-06	3.96e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CREBBP—lung cancer	7.47e-06	3.9e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ABCB1—lung cancer	7.37e-06	3.85e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—TYMS—lung cancer	7.24e-06	3.78e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTM1—lung cancer	7.16e-06	3.74e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PIK3CD—lung cancer	7.08e-06	3.7e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ALB—lung cancer	6.99e-06	3.65e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP1A1—lung cancer	6.78e-06	3.55e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ERCC2—lung cancer	6.73e-06	3.52e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PIK3CB—lung cancer	6.17e-06	3.23e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PTGS2—lung cancer	6.12e-06	3.2e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—APOA1—lung cancer	5.82e-06	3.04e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PTEN—lung cancer	5.34e-06	2.79e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PIK3CG—lung cancer	5.31e-06	2.78e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—EP300—lung cancer	5.09e-06	2.66e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—POMC—lung cancer	5.06e-06	2.64e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CREBBP—lung cancer	4.93e-06	2.57e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PIK3CD—lung cancer	4.67e-06	2.44e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALB—lung cancer	4.61e-06	2.41e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PIK3CB—lung cancer	4.07e-06	2.13e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PTGS2—lung cancer	4.03e-06	2.11e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PIK3CA—lung cancer	3.76e-06	1.97e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PTEN—lung cancer	3.52e-06	1.84e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—EP300—lung cancer	3.36e-06	1.75e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—AKT1—lung cancer	3.07e-06	1.61e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PIK3CA—lung cancer	2.48e-06	1.3e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—AKT1—lung cancer	2.03e-06	1.06e-05	CbGpPWpGaD
